NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/17/2024
Back to search
Official data from USPTO
ANTIDOTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
10/17/2024
Trademark type
Combined
Nice classes
35, 42, 44
Filing date
08/16/2016
Registration date
10/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2024
Last transaction
10/17/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/19/2016
First use in commerce
09/19/2016
Drawing code
3
Owner type
99
Owner location
LONDON, GB
Examiner
MARSH,BRANDON N
Current location
Historical data usage
Mark description
The mark consists of the word "antidote" in lower case letters followed by a three-line design.
Holders and representatives
Holders
ANTIDOTE TECHNOLOGIES LTD.
TrialReach Ltd.
Representatives
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Recruiting subjects for clinical healthcare trials
Class 42
Software as a service (SaaS) serviceshosting software for use by others for use in database management and patient referrals for clinical trials; providing temporary use of online nondownloadable computer software for management of clinical trialsmeasuring and monitoring the performance of clinical trialsfor identifying and recruiting patients for participation in clinical trialsfor matching patients with clinical trials; providing medical and scientific research information in the field of clinical trials; providing the service of matching individuals with clinical trials; providing clinical trial data and patient dataanalysis of such dataall for use in clinical trial planning and recruitment of patients for clinical trialsfor pharmaceutical development; cloud computing featuring software for use in analyzing clinical trial data and patient data in connection with medical and scientific researchclinical trial planning and pharmaceutical development; providing internet search engines; providing a website featuring a search engine that enables patients to discoverconnect with and participate in clinical trials; providing a website featuring medical and scientific research information related to clinical trials for the treatment of various conditions
Class 44
Providing a website featuring health and health care information for patients seeking medical treatment through participation in clinical trials
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2024
E815
TEAS SECTION 8 & 15 RECEIVED
04/22/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2023
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/05/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/03/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/27/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/26/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/26/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/26/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/26/2017
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
09/26/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/26/2017
GNRT
NON-FINAL ACTION E-MAILED
02/26/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/26/2017
DOCK
ASSIGNED TO EXAMINER
02/04/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/29/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/29/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/14/2016
IUAF
USE AMENDMENT FILED
12/06/2016
EISU
TEAS STATEMENT OF USE RECEIVED
12/06/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2016
PUBO
PUBLISHED FOR OPPOSITION
10/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2016
DOCK
ASSIGNED TO EXAMINER
09/03/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/20/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2016
NWAP
NEW APPLICATION ENTERED
08/19/2016
Continuous trademark protection
Get notified about every new filing that threatens ANTIDOTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.